Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Psychological Medicine|August 1, 1993
The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteersP M Grasby, K J Friston, C J Bench, et al.
Ciba Foundation Symposium|January 1, 1991
The neurotransmitter basis of cognition: psychopharmacological activation studies using positron emission tomographyK J Friston, P M Grasby, C D Frith, et al.
Nature|June 2, 1998
Evidence for striatal dopamine release during a video gameM J Koepp, R N Gunn, A D Lawrence, et al.
Archives of General Psychiatry|February 9, 2000
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatmentP A Sargent, K H Kjaer, C J Bench, et al.
The European Journal of Neuroscience|January 1, 1992
The effect of apomorphine and buspirone on regional cerebral blood flow during the performance of a cognitive task-measuring neuromodulatory effects of psychotropic drugs in manP M Grasby, K J Friston, C J Bench, et al.
Psychopharmacology|March 1, 1996
The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomographyC J Bench, A A Lammertsma, P M Grasby, et al.
Neuroimage|November 13, 1998
Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PETR N Gunn, P A Sargent, C J Bench, et al.
Psychopharmacology|January 1, 1993
Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-racloprideC J Bench, A A Lammertsma, R J Dolan, et al.
European Journal of Pharmacology|September 5, 1995
First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635V W Pike, J A McCarron, A A Lammerstma, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.
Pageof 5